These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 36820316)

  • 1. Characterization of a Novel Pathogen in Immunocompromised Patients:
    Yasmin M; Rojas LJ; Marshall SH; Hujer AM; Cmolik A; Marshall E; Boucher HW; Vila AJ; Soldevila M; Diene SM; Rolain JM; Bonomo RA
    Open Forum Infect Dis; 2023 Feb; 10(2):ofad014. PubMed ID: 36820316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MBLs, Rather Than Efflux Pumps, Led to Carbapenem Resistance in Fosfomycin and Aztreonam/Avibactam Resistant
    Chang Y; Zhang D; Niu S; Chen Q; Lin Q; Zhang X
    Infect Drug Resist; 2021; 14():315-327. PubMed ID: 33551643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can Ceftazidime-Avibactam and Aztreonam Overcome β-Lactam Resistance Conferred by Metallo-β-Lactamases in Enterobacteriaceae?
    Marshall S; Hujer AM; Rojas LJ; Papp-Wallace KM; Humphries RM; Spellberg B; Hujer KM; Marshall EK; Rudin SD; Perez F; Wilson BM; Wasserman RB; Chikowski L; Paterson DL; Vila AJ; van Duin D; Kreiswirth BN; Chambers HF; Fowler VG; Jacobs MR; Pulse ME; Weiss WJ; Bonomo RA
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28167541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Characteristics and Antimicrobial Susceptibility Profiles of
    Wang L; Zhang X; Li D; Hu F; Wang M; Guo Q; Yang F
    Infect Drug Resist; 2020; 13():247-256. PubMed ID: 32099417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of Cefotaxime-Resistant Escherichia coli Isolates from Healthy Cattle and Sheep in Northern Spain: Phenotypic and Genome-Based Characterization of Antimicrobial Susceptibility.
    Tello M; Ocejo M; Oporto B; Hurtado A
    Appl Environ Microbiol; 2020 Jul; 86(15):. PubMed ID: 32471914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The individual contributions of blaB, blaGOB and blaCME on MICs of β-lactams in Elizabethkingia anophelis.
    Chen PJ; Tan MC; Huang WC; Hsu SY; Chen TL; Yang CY; Kuo SC
    J Antimicrob Chemother; 2024 Jul; 79(7):1577-1580. PubMed ID: 38742706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli.
    Zhanel GG; Golden AR; Zelenitsky S; Wiebe K; Lawrence CK; Adam HJ; Idowu T; Domalaon R; Schweizer F; Zhanel MA; Lagacé-Wiens PRS; Walkty AJ; Noreddin A; Lynch Iii JP; Karlowsky JA
    Drugs; 2019 Feb; 79(3):271-289. PubMed ID: 30712199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial Activity of Ceftazidime-Avibactam and Comparators Against Fluoroquinolone-Resistant
    Kiratisin P; Arhin FF; Stone G; Utt E
    Microb Drug Resist; 2022 Nov; 28(11):1019-1027. PubMed ID: 36251881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activities of imipenem, vancomycin, and rifampicin against clinical Elizabethkingia species producing BlaB and GOB metallo-beta-lactamases.
    Chang TY; Chen HY; Chou YC; Cheng YH; Sun JR
    Eur J Clin Microbiol Infect Dis; 2019 Nov; 38(11):2045-2052. PubMed ID: 31352669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Draft genome sequence of carbapenem-resistant Elizabethkingia anophelis strain BP8467 clinical isolate from India.
    Amladi A; Lal Y B; Jacob JJ; Anandan S; Veeraraghavan B
    J Glob Antimicrob Resist; 2020 Jun; 21():200-202. PubMed ID: 32330579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbapenem resistance in Elizabethkingia meningoseptica is mediated by metallo-β-lactamase BlaB.
    González LJ; Vila AJ
    Antimicrob Agents Chemother; 2012 Apr; 56(4):1686-92. PubMed ID: 22290979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An NDM-Producing
    Simner PJ; Bergman Y; Conzemius R; Jacobs E; Tekle T; Beisken S; Tamma PD
    Open Forum Infect Dis; 2023 Jul; 10(7):ofad276. PubMed ID: 37416757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Last resort beta-lactam antibiotics for treatment of New-Delhi Metallo-Beta-Lactamase producing Enterobacterales and other Difficult-to-Treat Resistance in Gram-negative bacteria: A real-life study.
    Larcher R; Laffont-Lozes P; Roger C; Doncesco R; Groul-Viaud C; Martin A; Loubet P; Lavigne JP; Pantel A; Sotto A
    Front Cell Infect Microbiol; 2022; 12():1048633. PubMed ID: 36544909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. OXA-48-Mediated Ceftazidime-Avibactam Resistance Is Associated with Evolutionary Trade-Offs.
    Fröhlich C; Sørum V; Thomassen AM; Johnsen PJ; Leiros HS; Samuelsen Ø
    mSphere; 2019 Mar; 4(2):. PubMed ID: 30918055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic Diversity and in vitro Activity of Aztreonam/Avibactam and Ceftazidime/Avibactam Against Carbapenem-Resistant
    Sun S; Chen K; Kong X; Tian W; Niu S
    Infect Drug Resist; 2022; 15():2243-2251. PubMed ID: 35510161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting β-lactam resistance using whole genome sequencing in Klebsiella pneumoniae: the challenge of β-lactamase inhibitors.
    Hujer AM; Long SW; Olsen RJ; Taracila MA; Rojas LJ; Musser JM; Bonomo RA
    Diagn Microbiol Infect Dis; 2020 Nov; 98(3):115149. PubMed ID: 32858260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic diversity of chromosomal metallo-beta-lactamase genes in clinical isolates of Elizabethkingia meningoseptica from Korea.
    Yum JH; Lee EY; Hur SH; Jeong SH; Lee H; Yong D; Chong Y; Lee EW; Nordmann P; Lee K
    J Microbiol; 2010 Jun; 48(3):358-64. PubMed ID: 20571954
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Barnes MD; Winkler ML; Taracila MA; Page MG; Desarbre E; Kreiswirth BN; Shields RK; Nguyen MH; Clancy C; Spellberg B; Papp-Wallace KM; Bonomo RA
    mBio; 2017 Oct; 8(5):. PubMed ID: 29089425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic analysis of
    Hem S; Jarocki VM; Baker DJ; Charles IG; Drigo B; Aucote S; Donner E; Burnard D; Bauer MJ; Harris PNA; Wyrsch ER; Djordjevic SP
    Curr Res Microb Sci; 2022; 3():100083. PubMed ID: 34988536
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation of in-vitro susceptibility of ß-lactam-resistant Gram-negative bacilli to ceftazidime-avibactam and ceftolozane-tazobactam from clinical samples of a general hospital in southern Brazil.
    Carvalho TN; Kobs VC; Hille D; Deglmann RC; Melo LH; França PHC
    Rev Soc Bras Med Trop; 2023; 56():. PubMed ID: 36700602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.